32 participants
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-14
- Start Date:
- 2026-08-31
- Completion:
- 2028-03-31
Conditions
- Primary Light Chain (AL) Amyloidosis
Interventions
- DRUG
No Results Yet